免疫抑制
肝细胞癌
泛素连接酶
癌症研究
SOCS3
细胞因子信号抑制因子1
信号转导
医学
细胞因子
免疫学
生物
泛素
癌症
车站3
内科学
抑制器
细胞生物学
基因
生物化学
作者
Peixin Huang,Zhiying Zhao,Yi Chen,Biwei Yang,Jinglin Xia
标识
DOI:10.1038/s41374-022-00727-5
摘要
Hepatocellular carcinoma (HCC) is one of the most common primary liver malignancies and is the third leading cause of tumor-related mortality worldwide. Despite advances in HCC treatment, diagnosis at the later stages, and the complex mechanisms relating to the cause and pathogenesis, results in less than 40% of HCC patients being eligible for potential therapy. Prolonged inflammation and resulting immunosuppression are major hallmarks of HCC; however, the mechanisms responsible for these processes have not been clearly elucidated. In this study, we identified SOCS-7, an inhibitor of cytokine signaling, as a novel regulator of immunosuppression in HCC. We found that SOCS-7 mediated E3 ubiquitin ligase activity on a signaling adaptor molecule, Shc1, in Huh-7 cells. Overexpression of SOCS-7 reduced the induction of immunosuppressive factors, TGF-β, Versican, and Arginase-1, and further reduced STAT3 activation. Furthermore, using an in vivo tumor model, we confirmed that SOCS-7 negatively regulates immunosuppression and inhibits tumor growth by targeting Shc1 degradation. Together, our study identified SOCS-7 as a possible therapeutic target to reverse immunosuppression in HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI